Global Neuromuscular Blocking Drug Sales Market Report 2021

Publisher Name :
Date: 19-Jul-2021
No. of pages: 135
Inquire Before Buying

Neuromuscular blocking drugs cause paralysis of the affected skeletal muscles by blocking neuromuscular transmission at the neuromuscular junction.

Market Analysis and Insights: Global Neuromuscular Blocking Drug Market

The global Neuromuscular Blocking Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Neuromuscular Blocking Drug Scope and Market Size

The global Neuromuscular Blocking Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuromuscular Blocking Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Non-polarizing Agents

- Depolarizing Agents

Segment by Application

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

- Others

The Neuromuscular Blocking Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Neuromuscular Blocking Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Hikma Pharmaceuticals

- Merck

- Novartis

- Bayer

- Pfizer

- AbbVie

- GSK

Global Neuromuscular Blocking Drug Sales Market Report 2021

Table of Contents
1 Neuromuscular Blocking Drug Market Overview
1.1 Neuromuscular Blocking Drug Product Scope
1.2 Neuromuscular Blocking Drug Segment by Type
1.2.1 Global Neuromuscular Blocking Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Non-polarizing Agents
1.2.3 Depolarizing Agents
1.3 Neuromuscular Blocking Drug Segment by Application
1.3.1 Global Neuromuscular Blocking Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Neuromuscular Blocking Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Neuromuscular Blocking Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Neuromuscular Blocking Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Neuromuscular Blocking Drug Price Trends (2016-2027)
2 Neuromuscular Blocking Drug Estimates and Forecasts by Region
2.1 Global Neuromuscular Blocking Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Neuromuscular Blocking Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Neuromuscular Blocking Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Neuromuscular Blocking Drug Revenue Market Share by Region (2016-2021)
2.3 Global Neuromuscular Blocking Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Neuromuscular Blocking Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Neuromuscular Blocking Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Neuromuscular Blocking Drug Estimates and Projections (2016-2027)
2.4.2 Europe Neuromuscular Blocking Drug Estimates and Projections (2016-2027)
2.4.3 China Neuromuscular Blocking Drug Estimates and Projections (2016-2027)
2.4.4 Japan Neuromuscular Blocking Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Neuromuscular Blocking Drug Estimates and Projections (2016-2027)
2.4.6 India Neuromuscular Blocking Drug Estimates and Projections (2016-2027)
3 Global Neuromuscular Blocking Drug Competition Landscape by Players
3.1 Global Top Neuromuscular Blocking Drug Players by Sales (2016-2021)
3.2 Global Top Neuromuscular Blocking Drug Players by Revenue (2016-2021)
3.3 Global Neuromuscular Blocking Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromuscular Blocking Drug as of 2020)
3.4 Global Neuromuscular Blocking Drug Average Price by Company (2016-2021)
3.5 Manufacturers Neuromuscular Blocking Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Neuromuscular Blocking Drug Market Size by Type
4.1 Global Neuromuscular Blocking Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Neuromuscular Blocking Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Neuromuscular Blocking Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Neuromuscular Blocking Drug Price by Type (2016-2021)
4.2 Global Neuromuscular Blocking Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Neuromuscular Blocking Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Neuromuscular Blocking Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Neuromuscular Blocking Drug Price Forecast by Type (2022-2027)
5 Global Neuromuscular Blocking Drug Market Size by Application
5.1 Global Neuromuscular Blocking Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Neuromuscular Blocking Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Neuromuscular Blocking Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Neuromuscular Blocking Drug Price by Application (2016-2021)
5.2 Global Neuromuscular Blocking Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Neuromuscular Blocking Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Neuromuscular Blocking Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Neuromuscular Blocking Drug Price Forecast by Application (2022-2027)
6 North America Neuromuscular Blocking Drug Market Facts & Figures
6.1 North America Neuromuscular Blocking Drug Sales by Company
6.1.1 North America Neuromuscular Blocking Drug Sales by Company (2016-2021)
6.1.2 North America Neuromuscular Blocking Drug Revenue by Company (2016-2021)
6.2 North America Neuromuscular Blocking Drug Sales Breakdown by Type
6.2.1 North America Neuromuscular Blocking Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Neuromuscular Blocking Drug Sales Breakdown by Type (2022-2027)
6.3 North America Neuromuscular Blocking Drug Sales Breakdown by Application
6.3.1 North America Neuromuscular Blocking Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Neuromuscular Blocking Drug Sales Breakdown by Application (2022-2027)
7 Europe Neuromuscular Blocking Drug Market Facts & Figures
7.1 Europe Neuromuscular Blocking Drug Sales by Company
7.1.1 Europe Neuromuscular Blocking Drug Sales by Company (2016-2021)
7.1.2 Europe Neuromuscular Blocking Drug Revenue by Company (2016-2021)
7.2 Europe Neuromuscular Blocking Drug Sales Breakdown by Type
7.2.1 Europe Neuromuscular Blocking Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Neuromuscular Blocking Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Neuromuscular Blocking Drug Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Neuromuscular Blocking Drug Market Facts & Figures
8.1 China Neuromuscular Blocking Drug Sales by Company
8.1.1 China Neuromuscular Blocking Drug Sales by Company (2016-2021)
8.1.2 China Neuromuscular Blocking Drug Revenue by Company (2016-2021)
8.2 China Neuromuscular Blocking Drug Sales Breakdown by Type
8.2.1 China Neuromuscular Blocking Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Neuromuscular Blocking Drug Sales Breakdown by Type (2022-2027)
8.3 China Neuromuscular Blocking Drug Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Neuromuscular Blocking Drug Market Facts & Figures
9.1 Japan Neuromuscular Blocking Drug Sales by Company
9.1.1 Japan Neuromuscular Blocking Drug Sales by Company (2016-2021)
9.1.2 Japan Neuromuscular Blocking Drug Revenue by Company (2016-2021)
9.2 Japan Neuromuscular Blocking Drug Sales Breakdown by Type
9.2.1 Japan Neuromuscular Blocking Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Neuromuscular Blocking Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Neuromuscular Blocking Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Neuromuscular Blocking Drug Market Facts & Figures
10.1 Southeast Asia Neuromuscular Blocking Drug Sales by Company
10.1.1 Southeast Asia Neuromuscular Blocking Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Neuromuscular Blocking Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Neuromuscular Blocking Drug Sales Breakdown by Type
10.2.1 Southeast Asia Neuromuscular Blocking Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Neuromuscular Blocking Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Neuromuscular Blocking Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Neuromuscular Blocking Drug Market Facts & Figures
11.1 India Neuromuscular Blocking Drug Sales by Company
11.1.1 India Neuromuscular Blocking Drug Sales by Company (2016-2021)
11.1.2 India Neuromuscular Blocking Drug Revenue by Company (2016-2021)
11.2 India Neuromuscular Blocking Drug Sales Breakdown by Type
11.2.1 India Neuromuscular Blocking Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Neuromuscular Blocking Drug Sales Breakdown by Type (2022-2027)
11.3 India Neuromuscular Blocking Drug Sales Breakdown by Application
11.3.1 India Neuromuscular Blocking Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Neuromuscular Blocking Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Neuromuscular Blocking Drug Business
12.1 Hikma Pharmaceuticals
12.1.1 Hikma Pharmaceuticals Corporation Information
12.1.2 Hikma Pharmaceuticals Business Overview
12.1.3 Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Hikma Pharmaceuticals Neuromuscular Blocking Drug Products Offered
12.1.5 Hikma Pharmaceuticals Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Neuromuscular Blocking Drug Products Offered
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Neuromuscular Blocking Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Business Overview
12.4.3 Bayer Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer Neuromuscular Blocking Drug Products Offered
12.4.5 Bayer Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Neuromuscular Blocking Drug Products Offered
12.5.5 Pfizer Recent Development
12.6 AbbVie
12.6.1 AbbVie Corporation Information
12.6.2 AbbVie Business Overview
12.6.3 AbbVie Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AbbVie Neuromuscular Blocking Drug Products Offered
12.6.5 AbbVie Recent Development
12.7 GSK
12.7.1 GSK Corporation Information
12.7.2 GSK Business Overview
12.7.3 GSK Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GSK Neuromuscular Blocking Drug Products Offered
12.7.5 GSK Recent Development
...
13 Neuromuscular Blocking Drug Manufacturing Cost Analysis
13.1 Neuromuscular Blocking Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neuromuscular Blocking Drug
13.4 Neuromuscular Blocking Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neuromuscular Blocking Drug Distributors List
14.3 Neuromuscular Blocking Drug Customers
15 Market Dynamics
15.1 Neuromuscular Blocking Drug Market Trends
15.2 Neuromuscular Blocking Drug Drivers
15.3 Neuromuscular Blocking Drug Market Challenges
15.4 Neuromuscular Blocking Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Neuromuscular Blocking Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Neuromuscular Blocking Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Neuromuscular Blocking Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Neuromuscular Blocking Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Neuromuscular Blocking Drug Sales Market Share by Region (2016-2021)
Table 6. Global Neuromuscular Blocking Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Neuromuscular Blocking Drug Revenue Share by Region (2016-2021)
Table 8. Global Neuromuscular Blocking Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Neuromuscular Blocking Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Neuromuscular Blocking Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Neuromuscular Blocking Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Neuromuscular Blocking Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Neuromuscular Blocking Drug Sales Share by Company (2016-2021)
Table 14. Global Neuromuscular Blocking Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Neuromuscular Blocking Drug Revenue Share by Company (2016-2021)
Table 16. Global Neuromuscular Blocking Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromuscular Blocking Drug as of 2020)
Table 17. Global Neuromuscular Blocking Drug Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Neuromuscular Blocking Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Neuromuscular Blocking Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Neuromuscular Blocking Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Neuromuscular Blocking Drug Sales Share by Type (2016-2021)
Table 23. Global Neuromuscular Blocking Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Neuromuscular Blocking Drug Price (US$/Unit) by Type (2016-2021)
Table 25. Global Neuromuscular Blocking Drug Sales Share by Type (2022-2027)
Table 26. Global Neuromuscular Blocking Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Neuromuscular Blocking Drug Revenue Share by Type (2022-2027)
Table 28. Global Neuromuscular Blocking Drug Price (US$/Unit) by Type (2022-2027)
Table 29. Global Neuromuscular Blocking Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Neuromuscular Blocking Drug Sales Share by Application (2016-2021)
Table 31. Global Neuromuscular Blocking Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Neuromuscular Blocking Drug Price (US$/Unit) by Application (2016-2021)
Table 33. Global Neuromuscular Blocking Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Neuromuscular Blocking Drug Sales Share by Application (2022-2027)
Table 35. Global Neuromuscular Blocking Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Neuromuscular Blocking Drug Revenue Share by Application (2022-2027)
Table 37. Global Neuromuscular Blocking Drug Price (US$/Unit) by Application (2022-2027)
Table 38. North America Neuromuscular Blocking Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Neuromuscular Blocking Drug Sales Market Share by Company (2016-2021)
Table 40. North America Neuromuscular Blocking Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Neuromuscular Blocking Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Neuromuscular Blocking Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Neuromuscular Blocking Drug Sales Market Share by Type (2016-2021)
Table 44. North America Neuromuscular Blocking Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Neuromuscular Blocking Drug Sales Market Share by Type (2022-2027)
Table 46. North America Neuromuscular Blocking Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Neuromuscular Blocking Drug Sales Market Share by Application (2016-2021)
Table 48. North America Neuromuscular Blocking Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Neuromuscular Blocking Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Neuromuscular Blocking Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Neuromuscular Blocking Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Neuromuscular Blocking Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Neuromuscular Blocking Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Neuromuscular Blocking Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Neuromuscular Blocking Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Neuromuscular Blocking Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Neuromuscular Blocking Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Neuromuscular Blocking Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Neuromuscular Blocking Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Neuromuscular Blocking Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Neuromuscular Blocking Drug Sales Market Share by Application (2022-2027)
Table 62. China Neuromuscular Blocking Drug Sales (K Units) by Company (2016-2021)
Table 63. China Neuromuscular Blocking Drug Sales Market Share by Company (2016-2021)
Table 64. China Neuromuscular Blocking Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Neuromuscular Blocking Drug Revenue Market Share by Company (2016-2021)
Table 66. China Neuromuscular Blocking Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Neuromuscular Blocking Drug Sales Market Share by Type (2016-2021)
Table 68. China Neuromuscular Blocking Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Neuromuscular Blocking Drug Sales Market Share by Type (2022-2027)
Table 70. China Neuromuscular Blocking Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Neuromuscular Blocking Drug Sales Market Share by Application (2016-2021)
Table 72. China Neuromuscular Blocking Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Neuromuscular Blocking Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Neuromuscular Blocking Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Neuromuscular Blocking Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Neuromuscular Blocking Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Neuromuscular Blocking Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Neuromuscular Blocking Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Neuromuscular Blocking Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Neuromuscular Blocking Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Neuromuscular Blocking Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Neuromuscular Blocking Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Neuromuscular Blocking Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Neuromuscular Blocking Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Neuromuscular Blocking Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Neuromuscular Blocking Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Neuromuscular Blocking Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Neuromuscular Blocking Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Neuromuscular Blocking Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Neuromuscular Blocking Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Neuromuscular Blocking Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Neuromuscular Blocking Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Neuromuscular Blocking Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Neuromuscular Blocking Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Neuromuscular Blocking Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Neuromuscular Blocking Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Neuromuscular Blocking Drug Sales Market Share by Application (2022-2027)
Table 98. India Neuromuscular Blocking Drug Sales (K Units) by Company (2016-2021)
Table 99. India Neuromuscular Blocking Drug Sales Market Share by Company (2016-2021)
Table 100. India Neuromuscular Blocking Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Neuromuscular Blocking Drug Revenue Market Share by Company (2016-2021)
Table 102. India Neuromuscular Blocking Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Neuromuscular Blocking Drug Sales Market Share by Type (2016-2021)
Table 104. India Neuromuscular Blocking Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Neuromuscular Blocking Drug Sales Market Share by Type (2022-2027)
Table 106. India Neuromuscular Blocking Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Neuromuscular Blocking Drug Sales Market Share by Application (2016-2021)
Table 108. India Neuromuscular Blocking Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Neuromuscular Blocking Drug Sales Market Share by Application (2022-2027)
Table 110. Hikma Pharmaceuticals Corporation Information
Table 111. Hikma Pharmaceuticals Description and Business Overview
Table 112. Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Hikma Pharmaceuticals Neuromuscular Blocking Drug Product
Table 114. Hikma Pharmaceuticals Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Merck Neuromuscular Blocking Drug Product
Table 119. Merck Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Novartis Neuromuscular Blocking Drug Product
Table 124. Novartis Recent Development
Table 125. Bayer Corporation Information
Table 126. Bayer Description and Business Overview
Table 127. Bayer Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Bayer Neuromuscular Blocking Drug Product
Table 129. Bayer Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Pfizer Neuromuscular Blocking Drug Product
Table 134. Pfizer Recent Development
Table 135. AbbVie Corporation Information
Table 136. AbbVie Description and Business Overview
Table 137. AbbVie Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. AbbVie Neuromuscular Blocking Drug Product
Table 139. AbbVie Recent Development
Table 140. GSK Corporation Information
Table 141. GSK Description and Business Overview
Table 142. GSK Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. GSK Neuromuscular Blocking Drug Product
Table 144. GSK Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Neuromuscular Blocking Drug Distributors List
Table 148. Neuromuscular Blocking Drug Customers List
Table 149. Neuromuscular Blocking Drug Market Trends
Table 150. Neuromuscular Blocking Drug Market Drivers
Table 151. Neuromuscular Blocking Drug Market Challenges
Table 152. Neuromuscular Blocking Drug Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuromuscular Blocking Drug Product Picture
Figure 2. Global Neuromuscular Blocking Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Neuromuscular Blocking Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Pharmacy Examples
Figure 7. Retail Pharmacy Examples
Figure 8. Online Pharmacy Examples
Figure 9. Others Examples
Figure 10. Global Neuromuscular Blocking Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Neuromuscular Blocking Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Neuromuscular Blocking Drug Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Neuromuscular Blocking Drug Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 14. Global Neuromuscular Blocking Drug Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Neuromuscular Blocking Drug Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Neuromuscular Blocking Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Neuromuscular Blocking Drug Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Neuromuscular Blocking Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Neuromuscular Blocking Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Neuromuscular Blocking Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Neuromuscular Blocking Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Neuromuscular Blocking Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Neuromuscular Blocking Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Neuromuscular Blocking Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Neuromuscular Blocking Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Neuromuscular Blocking Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Neuromuscular Blocking Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Neuromuscular Blocking Drug Players Market Share by Revenue in Neuromuscular Blocking Drug: 2016 & 2020
Figure 29. Neuromuscular Blocking Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Neuromuscular Blocking Drug Revenue Share by Type (2016-2021)
Figure 31. Global Neuromuscular Blocking Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Neuromuscular Blocking Drug Revenue Share by Application (2016-2021)
Figure 33. Global Neuromuscular Blocking Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Neuromuscular Blocking Drug Sales Market Share by Type in 2020
Figure 35. North America Neuromuscular Blocking Drug Sales Market Share by Application in 2020
Figure 36. Europe Neuromuscular Blocking Drug Sales Market Share by Type in 2020
Figure 37. Europe Neuromuscular Blocking Drug Sales Market Share by Application in 2020
Figure 38. China Neuromuscular Blocking Drug Sales Market Share by Type in 2020
Figure 39. China Neuromuscular Blocking Drug Sales Market Share by Application in 2020
Figure 40. Japan Neuromuscular Blocking Drug Sales Market Share by Type in 2020
Figure 41. Japan Neuromuscular Blocking Drug Sales Market Share by Application in 2020
Figure 42. Southeast Asia Neuromuscular Blocking Drug Sales Market Share by Type in 2020
Figure 43. Southeast Asia Neuromuscular Blocking Drug Sales Market Share by Application in 2020
Figure 44. India Neuromuscular Blocking Drug Sales Market Share by Type in 2020
Figure 45. India Neuromuscular Blocking Drug Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Neuromuscular Blocking Drug
Figure 48. Manufacturing Process Analysis of Neuromuscular Blocking Drug
Figure 49. Neuromuscular Blocking Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
  • Global Posaconazole Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 131
    Posaconazole is an antifungal medicine that fights certain infections caused by fungus. Posaconazole is used to prevent fungal infections in people who have a weak immune system resulting from certain treatments or conditions (such as chemotherapy, stem cell transplantation, HIV infection, and others). Market Analysis and Insights: Global Posaconazole Market The global Posaconazole market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing......
  • Global Fluconazole Drug Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 148
    Fluconazole is an antifungal medicine. Fluconazole is used to treat infections caused by fungus, which can invade any part of the body including the mouth, throat, esophagus, lungs, bladder, genital area, and the blood. Market Analysis and Insights: Global Fluconazole Drug Market The global Fluconazole Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Fluconazole Drug S......
  • Global Itraconazole Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 140
    Itraconazole is an antifungal medication used to treat a number of fungal infections. This includes aspergillosis, blastomycosis, coccidioidomycosis, histoplasmosis, and paracoccidioidomycosis. It may be given by mouth or intravenously. Common side effects include nausea, diarrhea, abdominal pain, rash, and headache. Market Analysis and Insights: Global Itraconazole Market The global Itraconazole market was valued at US$ XX in 2020 and will reach US$ XX million by the end o......
  • Global Lasix Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 136
    Lasix is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. It may also be used for the treatment of high blood pressure. It can be taken by injection into a vein or by mouth. Market Analysis and Insights: Global Lasix Market The global Lasix market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Lasix Scope and Market Size T......
  • Global Albendazole Drug Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 131
    Albendazole is a medication used for the treatment of a variety of parasitic worm infestations. It is useful for giardiasis, trichuriasis, filariasis, neurocysticercosis, hydatid disease, pinworm disease, and ascariasis, among others. It is taken by mouth. Market Analysis and Insights: Global Albendazole Drug Market The global Albendazole Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.......
  • Global Cyromazine Drug Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 136
    Cyromazine has CAS No. 66215-27-8, Mol. Wt. 166.18gms/mol, Molecular formula C6 H10N6 . Cyromazine acts as an effective antiparasitic agent for Veterinary use to control diseases like Scabies, Pediculosis etc. These diseases are called as Ectoparasitic diseases which need an effective Ectoparasiticide, that is an anti-ectoparasitic like Cyromazine that attacks parasites like ticks , leeches which live on the surface of the animal and suck their blood. Hence it is used to control the growth of su......
  • Global Veterinary Autogenous Vaccines Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 143
    The autogenous vaccine is a vaccine prepared from cultures of microorganisms obtained from an individual and then used to immunize that same individual against further spread and progress of the same microorganisms. Market Analysis and Insights: Global Veterinary Autogenous Vaccines Market The global Veterinary Autogenous Vaccines market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. G......
  • Global Bone Growth Stimulant Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 134
    Market Analysis and Insights: Global Bone Growth Stimulant Market The global Bone Growth Stimulant market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Bone Growth Stimulant Scope and Market Size The global Bone Growth Stimulant market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Growth Stimulan......
  • Global Aticaine Hydrochloride Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 138
    Market Analysis and Insights: Global Aticaine Hydrochloride Market The global Aticaine Hydrochloride market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Aticaine Hydrochloride Scope and Market Size The global Aticaine Hydrochloride market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Aticaine Hydroch......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs